<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01799980</url>
  </required_header>
  <id_info>
    <org_study_id>2009471-01H</org_study_id>
    <nct_id>NCT01799980</nct_id>
  </id_info>
  <brief_title>Evaluation of Endobronchial Ultrasound (EBUS) for Staging Lung Cancer</brief_title>
  <acronym>EBUS</acronym>
  <official_title>Evaluation of Endobronchial Ultrasound (EBUS) for Staging Lung Cancer</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ottawa Hospital Research Institute</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Ottawa Hospital Research Institute</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study will compare two different methods of staging lung cancer to determine whether
      endobronchial ultrasound (EBUS) staging of mediastinal lymph nodes will provide good
      diagnostic yield in detecting lung cancer, when compared to current methods of a staging
      bronchoscopy and cervical mediastinoscopy.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>June 2012</start_date>
  <completion_date type="Actual">December 2018</completion_date>
  <primary_completion_date type="Actual">December 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Lung cancer staging</measure>
    <time_frame>Pre-op and post-op</time_frame>
    <description>Lung cancer staging (assessed by either cervical mediastinoscopy or EBUS) will be compared both pre-op and post-op.</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">37</enrollment>
  <condition>Lung Cancer</condition>
  <arm_group>
    <arm_group_label>Cervical mediastinoscopy</arm_group_label>
    <description>This group will undergo cervical mediastinoscopy before surgery to stage their lung cancer (procedure decided by the surgeon).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Endo-bronchial ultrasound</arm_group_label>
    <description>This group will undergo endobronchial ultrasound before surgery to stage their lung cancer (procedure decided by the surgeon).</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Patients undergoing a staging procedure for lung cancer (either cervical mediastinoscopy or
        endobronchial ultrasound).
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

        Patients, &gt; 18 years of age,

        Gender- Males and Female

        Diagnosis of Non Small Cell Lung Cancer.

        Patients who have consented on an Ottawa Hospital consent form to undergo a mediastinoscopy
        procedure or EBUS-TBNA, and a Positron emission tomography (PET) of the chest for lung
        cancer staging.

        Exclusion Criteria:

        Females who are pregnant (or found to be pregnant) during the course of this research
        study.

        Patients who do not provide their Ottawa Hospital consent to undergo a staging bronchoscopy
        , cervical mediastinoscopy or EBUS-TBNA.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Donna E Maziak, MD, MSc</last_name>
    <role>Principal Investigator</role>
    <affiliation>Ottawa Hospital Research Institute</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Ottawa Hospital Research Institute</name>
      <address>
        <city>Ottawa</city>
        <state>Ontario</state>
        <zip>K1H8L6</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>March 2019</verification_date>
  <study_first_submitted>February 25, 2013</study_first_submitted>
  <study_first_submitted_qc>February 25, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 27, 2013</study_first_posted>
  <last_update_submitted>March 19, 2019</last_update_submitted>
  <last_update_submitted_qc>March 19, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">March 21, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Lung cancer</keyword>
  <keyword>Cervical mediastinoscopy</keyword>
  <keyword>Endobronchial ultrasound</keyword>
  <keyword>Staging</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lung Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

